Target Name: ZMYM4-AS1
NCBI ID: G100861513
Other Name(s): ZMYM4 antisense RNA 1 (non-protein coding) | ZMYM4 antisense RNA 1

ZMYM4-AS1: A Potential Drug Target and Biomarker

ZMYM4-AS1, a protein encoded by the ZMYM4 gene, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. ZMYM4-AS1 is a scaffold protein that plays a critical role in the regulation of cell division and has been shown to be involved in various cellular processes, including the development and progression of cancer.

The ZMYM4 gene is located on chromosome 6p and encodes a protein that is essential for cell signaling, specifically in the regulation of the actin cytoskeleton. The cytoskeleton is a complex network of proteins that provides structural support to the cell and helps maintain cell shape and integrity. ZMYM4-AS1 is a key regulator of the cytoskeleton and has been shown to play a crucial role in the development and progression of various diseases.

One of the most significant findings related to ZMYM4-AS1 is its involvement in the regulation of cell division. In cancer, abnormal cell division is a major contributing factor to the development and progression of cancer. ZMYM4-AS1 has been shown to regulate the growth and division of cancer cells, which may have implications for the development of new cancer therapies.

In addition to its role in cell division, ZMYM4-AS1 has also been shown to play a role in the regulation of cell signaling pathways. Specifically, ZMYM4-AS1 has been shown to be involved in the regulation of the TGF-β pathway, a critical pathway involved in the development and progression of many diseases, including cancer.

ZMYM4-AS1 has also been shown to be involved in the regulation of theNotch signaling pathway, a critical pathway involved in the development and regulation of stem cells and many diseases, including cancer. TheNotch signaling pathway plays a role in the regulation of cell fates and has been implicated in the development of many diseases, including cancer.

In conclusion, ZMYM4-AS1 is a protein that has been identified as a potential drug target and biomarker for various diseases. Its involvement in the regulation of cell division, signaling pathways, and the regulation of cell fates makes it an attractive target for new therapies. Further research is needed to fully understand the role of ZMYM4-AS1 in the development and progression of various diseases and to develop new treatments based on its potential as a drug target and biomarker.

Protein Name: ZMYM4 Antisense RNA 1

More Common Targets

ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P